Your browser doesn't support javascript.
loading
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent.
Goikoetxea-Usandizaga, Naroa; Bravo, Miren; Egia-Mendikute, Leire; Abecia, Leticia; Serrano-Maciá, Marina; Urdinguio, Rocío G; Clos-García, Marc; Rodríguez-Agudo, Rubén; Araujo-Legido, Raquel; López-Bermudo, Lucía; Delgado, Teresa C; Lachiondo-Ortega, Sofía; González-Recio, Irene; Gil-Pitarch, Clàudia; Peña-Cearra, Ainize; Simón, Jorge; Benedé-Ubieto, Raquel; Ariño, Silvia; Herranz, Jose M; Azkargorta, Mikel; Salazar-Bermeo, Julio; Martí, Nuria; Varela-Rey, Marta; Falcón-Pérez, Juan M; Lorenzo, Óscar; Nogueiras, Rubén; Elortza, Félix; Nevzorova, Yulia A; Cubero, Francisco J; Saura, Domingo; Martínez-Cruz, Luis Alfonso; Sabio, Guadalupe; Palazón, Asís; Sancho-Bru, Pau; Elguezabal, Natalia; Fraga, Mario F; Ávila, Matías A; Bataller, Ramón; Marín, José J G; Martín, Franz; Martínez-Chantar, María Luz.
Afiliação
  • Goikoetxea-Usandizaga N; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Bravo M; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Egia-Mendikute L; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Abecia L; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Serrano-Maciá M; Cancer Immunology and Immunotherapy Lab, Centre for Cooperative Research in Biosciences CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Urdinguio RG; Inflammation and Macrophage Plasticity Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Clos-García M; Immunology, Microbiology and Parasitology Department, Medicine and Nursing Faculty, University of the Basque Country (UPV/EHU), Leioa, Spain.
  • Rodríguez-Agudo R; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Araujo-Legido R; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • López-Bermudo L; Cancer Epigenetics and Nanomedicine Laboratory, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), El Entrego, Spain.
  • Delgado TC; Health Research Institute of Asturias (ISPA), Oviedo, Spain.
  • Lachiondo-Ortega S; University Institute of Oncology (IUOPA), University of Oviedo, Oviedo, Spain.
  • González-Recio I; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERer), Madrid, Spain.
  • Gil-Pitarch C; Exosomes Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Peña-Cearra A; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Simón J; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Benedé-Ubieto R; Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), University of Pablo de Olavide-University of Sevilla-CSIC, Seville, Spain.
  • Ariño S; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas (CIBERdem), Spain.
  • Herranz JM; Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), University of Pablo de Olavide-University of Sevilla-CSIC, Seville, Spain.
  • Azkargorta M; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas (CIBERdem), Spain.
  • Salazar-Bermeo J; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Martí N; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Varela-Rey M; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Falcón-Pérez JM; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Lorenzo Ó; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Nogueiras R; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Elortza F; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Nevzorova YA; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Cubero FJ; Inflammation and Macrophage Plasticity Laboratory, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Saura D; Liver Disease Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Martínez-Cruz LA; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Sabio G; Department of Immunology, Ophthalmology and ENT Complutense University School of Medicine Madrid Spain.
  • Palazón A; Gregorio Maraóón Health Research Institute, Madrid, Spain.
  • Sancho-Bru P; Department of Genetics, Physiology and Microbiology. Faculty of Biology. Complutense University of Madrid, Madrid, Spain.
  • Elguezabal N; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Fraga MF; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
  • Ávila MA; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas (CIBERdem), Spain.
  • Bataller R; Instituto de Investigaciones Sanitarias de Navarra-IdiSNA, Pamplona, Spain.
  • Marín JJG; Hepatology Program, Cima-University of Navarra, Navarra, Spain.
  • Martín F; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Martínez-Chantar ML; Proteomics Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
Hepatology ; 78(3): 878-895, 2023 09 01.
Article em En | MEDLINE | ID: mdl-36745935

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatias Alcoólicas Tipo de estudo: Guideline / Risk_factors_studies Limite: Animals Idioma: En Revista: Hepatology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatias Alcoólicas Tipo de estudo: Guideline / Risk_factors_studies Limite: Animals Idioma: En Revista: Hepatology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha País de publicação: Estados Unidos